OTHER GROUP COMPANIES
market

Marksans Pharma stock up by 14% as board considers share buyback

The stock reached its 52-week high on July 6, 2021, at Rs93.50, and its 52-week low on June 20, 2022, at Rs38.70.

July 05, 2022 10:13 IST | India Infoline News Service
The decision to examine a share buyback proposal by the business board caused the share price of Marksans Pharma to increase by more than 14% in early trading on July 5.

The stock reached its 52-week high on July 6, 2021, at Rs93.50, and its 52-week low on June 20, 2022, at Rs38.70.

On Friday, July 8, 2022, a board of directors meeting of Marksans Pharma is planned to take place to discuss the proposal for the repurchase of fully paid-up equity shares of the company up to the total amount of the company's equity share capital and free reserves that the board may determine. The company informed about this in its press release.

As of 10:15 am, the stock is trading at Rs49.60, up 14.55% from the previous close.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity